Why India's Pharma Giants Are Betting on Chronic Business?
India's top pharma companies shift focus to chronic therapies, target post-patent GLP-1 market, and make major acquisitions, with FY27 set to test...
85 Views
Sun Pharmaceutical (SUNP IN): Organon Acquisition to Enhance Scale At the Cost of Growth
Sun Pharma to acquire Organon for $14 per share in all-cash deal, boosting innovative medicines business revenue share to 27%, up from 20% now....
130 Views
Sun Pharmaceutical Industries: Organon M&A Provides Scale, Growth Revival Key.
Sun Pharma has entered into a definitive agreement to acquire Organon & Co (Organon) in an all-cash transaction deal (all outstanding shares)
123 Views
Top APAC (Ex-China) Investment Worthy Healthcare Companies Using Smartkarma’s Smart Score Screener
We have screened APAC (ex-China) healthcare companies with market cap≥$800M using Smartkarma’s Smart Score and picked up 2 investable ideas by...
604 Views
The GLP-1 Super-Cycle: Deconstructing India’s 2026 Patent Cliff and Alpha Generators
Semaglutide patent expiration in India leads to 70% price drop, increasing access to affordable generic versions for obesity and diabetes treatment.
291 Views